Evidence map›Paper›PMID 26992945›Full record

Trial reportHaematologica2016

APRIL levels are associated with disease activity in human chronic graft-versus-host disease.

François Chasset, Adèle de Masson, Hélène Le Buanec, Aliénor Xhaard, Flore Sicre de Fontbrune, Marie Robin, Michel Rybojad, Nathalie Parquet, Anne C Brignier, Tereza Coman and 7 more

Open access · goldAbstract readClinical TrialLetter
In one paragraph

Trial report in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

François ChassetINSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris.
Adèle de MassonINSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris.
Hélène Le BuanecINSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité
Aliénor XhaardUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris.
Flore Sicre de FontbruneUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris.
Marie RobinUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris.
Michel RybojadUniversity Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris.
Nathalie ParquetUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris Therapeutic Apheresis Unit, Saint-Louis Hospital, Paris.
Anne C BrignierUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris Therapeutic Apheresis Unit, Saint-Louis Hospital, Paris.
Tereza ComanUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris.
Djaouida BengoufaUniversity Paris Diderot, Sorbonne Paris Cité Immunobiology Department, Saint-Louis Hospital, Paris.
Anne BergeronUniversity Paris Diderot, Sorbonne Paris Cité Pneumology Department, Saint-Louis Hospital, Paris.
Régis Peffault de LatourUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris.
Martine BagotINSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris.
Armand BensussanINSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité
Gérard SociéUniversity Paris Diderot, Sorbonne Paris Cité Hematology and Transplantation, Saint-Louis Hospital, Paris INSERM and UMRS1160, France gerard.socie@aphp.fr.
Jean-David BouazizINSERM and UMRS 976, Laboratory of Onco dermatology, Immunology, and Cutaneous Stem cells, F-75739 Paris University Paris Diderot, Sorbonne Paris Cité Dermatology Department, Saint-Louis Hospital, Paris.
Sorbonne Paris Cité · FRUniversité Paris Cité · FRHôpital Saint-Louis · FRDélégation Paris 7 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationAdultAgedAllograftsB-LymphocytesChronic DiseaseFemaleGraft vs Host DiseaseHumansMaleMiddle AgedProspective StudiesTumor Necrosis Factor Ligand Superfamily Member 13TNFSF13 protein, humanTumor Necrosis Factor Ligand Superfamily Member 13APRILautoantibodyBAFFB cell homeostasischronic graft-versus-host disease

Identifiers

PMID26992945
PMCPMC5004480
OpenAlexW2310563536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.